Double-blind , placebo-controlled trial in HIV + with CD@ ( + ) T cells/L ( CD@ ) @ randomized to receive the @-valent pneumococcal polysaccharide vaccine ( PPV@ ) or placebo at enrollment , followed by placebo or PPV@ , respectively , @-@ months later ( after @ months of ART ) .